World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
31299
World Ranking
14475
National Ranking
7321

Richard C. Shelton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard C. Shelton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 367 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard C. Shelton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard C. Shelton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard C. Shelton is affiliated with the University of Alabama at Birmingham in the United States. Their research spans primarily the fields of Medicine and Neuroscience, with a significant focus on subfields such as Pharmacology, Biological Psychiatry, Psychiatry and Mental Health, Clinical Psychology, and Cognitive Neuroscience.

The scientist's main topics of study include:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Functional Brain Connectivity Studies
  • Stress Responses and Cortisol
  • Mental Health Research Topics
  • Transcranial Magnetic Stimulation Studies

Richard C. Shelton has published extensively with several frequent coauthors, including Matthew Macaluso, George I. Papakostas, Madhukar H. Trivedi, Manish K. Jha, and Maurizio Fava.

The scientist's recent publications include:

  • "A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials," 2021, Molecular Psychiatry
  • "Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals," 2023, Molecular Psychiatry
  • "Obesity, inflammation, and depression in adolescents," 2023, Frontiers in Psychiatry
  • "Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial of a Kappa-Selective Opioid Receptor Antagonist Augmentation in Treatment-Resistant Depression," 2020, Annals of Clinical Psychiatry
  • "The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder," 2022, Journal of Affective Disorders

Key publication venues for their work include:

  • Journal of Affective Disorders
  • Molecular Psychiatry
  • Frontiers in Psychiatry
  • Annals of Clinical Psychiatry
  • International Journal of Bipolar Disorders

In addition to journal articles, Shelton has contributed to book publications, such as "Drug Development in Psychiatry," published by Springer International Publishing in 2023.

Best Publications

  • Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis

    Jay C. Fournier;Robert J. DeRubeis;Steven D. Hollon;Sona Dimidjian

  • Cognitive therapy vs medications in the treatment of moderate to severe depression.

    Robert J. DeRubeis;Steven D. Hollon;Jay D. Amsterdam;Richard C. Shelton

  • Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

    Steven D. Hollon;Robert J. DeRubeis;Richard C. Shelton;Jay D. Amsterdam

  • A novel augmentation strategy for treating resistant major depression.

    Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  • Effort-Based Decision-Making in Major Depressive Disorder: A Translational Model of Motivational Anhedonia

    Michael T. Treadway;Nicholas A. Bossaller;Richard C. Shelton;David H. Zald

  • Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

    Vanina Popova;Ella J. Daly;Madhukar Trivedi;Kimberly Cooper

  • Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

    Ella J. Daly;Jaskaran B. Singh;Maggie Fedgchin;Kimberly Cooper

  • Effectiveness of St John's wort in major depression: A randomized controlled trial

    Richard C. Shelton;Martin B. Keller;Allan Gelenberg;David L. Dunner

  • Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

    Ella J. Daly;Madhukar H. Trivedi;Adam Janik;Honglan Li

  • A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

    Jaskaran B. Singh;Maggie Fedgchin;Ella J. Daly;Peter De Boer

  • Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression

    R C Shelton;J Claiborne;M Sidoryk-Wegrzynowicz;R Reddy

  • Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology

    Heath D Schmidt;Richard C Shelton;Ronald S Duman

  • Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

    A. John Rush;Madhukar H. Trivedi;Jonathan W. Stewart;Andrew A. Nierenberg

  • Prediction of Response to Medication and Cognitive Therapy in the Treatment of Moderate to Severe Depression

    Jay C. Fournier;Robert J. DeRubeis;Richard C. Shelton;Steven D. Hollon

  • Personality change during depression treatment: a placebo-controlled trial.

    Tony Z. Tang;Robert J. DeRubeis;Steven D. Hollon;Jay Amsterdam

  • Cognitive therapy and pharmacotherapy for depression.

    Steven D. Hollon;Richard C. Shelton;Peter T. Loosen

  • Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

    George I. Papakostas;Michael E. Thase;Michael E. Thase;Maurizio Fava;J. Craig Nelson

  • Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features

    A. John Rush;Mark Zimmerman;Stephen R. Wisniewski;Maurizio Fava

  • Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.

    George I. Papakostas;Richard C. Shelton;Juliana Smith;Maurizio Fava

  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

    George I. Papakostas;Richard C. Shelton;John M. Zajecka;Bijan Etemad

Frequent Co-Authors

Michael E. Thase
Michael E. Thase University of Pennsylvania
Madhukar H. Trivedi
Madhukar H. Trivedi The University of Texas Southwestern Medical Center
Maurizio Fava
Maurizio Fava Harvard University
William V. Bobo
William V. Bobo Mayo Clinic
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Steven D. Hollon
Steven D. Hollon Vanderbilt University
Edward S. Friedman
Edward S. Friedman University of Pittsburgh
Mauricio Tohen
Mauricio Tohen University of New Mexico
George I. Papakostas
George I. Papakostas Harvard University
Thilo Deckersbach
Thilo Deckersbach Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA is diverse, and online degrees now offer greater flexibility for students and professionals. Several online degree pathways complement or extend your medical and healthcare studies, making advanced roles more accessible while balancing work and personal commitments.

For those interested in healthcare administration, earning a degree from one of the cahme accredited programs ensures the highest standards for online master's in health administration. Nursing professionals can progress with options such as the rn to bsn online without clinicals, designed for working nurses seeking advancement without additional in-person clinical requirements.

For those aiming for the highest level of nursing practice, consider the fastest dnp program to accelerate your career growth. Additionally, students who prefer less-intensive research requirements may be interested in accredited dnp programs without dissertation. Each of these online pathways broadens career possibilities and offers non-traditional students greater control over their professional futures in healthcare.

Best Scientists Citing Richard C. Shelton

Trending Scientists

Recently Published Articles